Jet.AI to Present at the Maxim Group Virtual TMT Conference on Tuesday, June 4, 2024
May 31, 2024 08:30 ET
|
Jet.AI. Inc.
LAS VEGAS, May 31, 2024 (GLOBE NEWSWIRE) -- Jet.AI Inc. (“Jet.AI” or the “Company”) (NASDAQ: JTAI), an innovative private aviation and artificial intelligence (“AI”) company, will be presenting at...
Inuvo CEO to Participate in Fireside Chat at the Maxim Group TMT Conference on June 5, 2024
May 31, 2024 08:30 ET
|
Inuvo Inc.
LITTLE ROCK, Ark., May 31, 2024 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE American: INUV), a leading provider of marketing technology, powered by artificial intelligence (AI) that serves brands and...
Morphic to Participate in Jefferies Global Healthcare Conference
May 31, 2024 08:00 ET
|
Morphic Therapeutic
WALTHAM, Mass., May 31, 2024 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious...
Milestone® Pharmaceuticals to Participate in the Upcoming Jefferies Global Healthcare Conference
May 31, 2024 08:00 ET
|
Milestone Pharmaceuticals Inc.
MONTREAL and CHARLOTTE, N.C., May 31, 2024 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced that members of its management team will participate in the Jefferies...
Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
May 31, 2024 07:30 ET
|
Adaptive Biotechnologies
SEATTLE, May 31, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
atai Life Sciences to Participate in the Jefferies 2024 Global Healthcare Conference
May 31, 2024 07:00 ET
|
atai Life Sciences
NEW YORK and BERLIN, May 31, 2024 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental...
Immuron CEO Steven Lydeamore to present at Peak Sky High
May 31, 2024 06:00 ET
|
Immuron Limited
MELBOURNE, Australia, May 31, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, is pleased to advise our Chief...
United Renewables CEO Applauds Outcomes of Green Vision Summit, Aiming for Net-Zero by 2050
May 31, 2024 05:10 ET
|
United Renewables Limited
United Renewables CEO applauds outcomes of Green Vision Summit, highlighting youth engagement and commitment to net-zero by 2050
Mountain Assets Invites Investors to Exclusive Site Visit of Lake Narracan Project
May 31, 2024 00:43 ET
|
Mountain Assets
The team at Mountain Assets has been in partnership with Star Investment Group for over 3 years and has arranged a site visit to meet potential investors.
ADC Therapeutics nimmt an der Jefferies Global Healthcare Conference teil
May 30, 2024 19:40 ET
|
ADC Therapeutics SA
LAUSANNE, Schweiz, May 31, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) gab heute bekannt, dass Ameet Mallik, Chief Executive Officer, am Donnerstag, 6. Juni 2024 um 11:30 Uhr ET an der...